Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 3
1987 2
1988 2
1989 1
1995 1
2002 2
2007 1
2008 5
2009 5
2010 4
2011 4
2012 2
2013 5
2014 6
2015 6
2016 3
2017 3
2018 1
2019 1
2020 6
2021 5
2022 3
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Mendoza N, et al. Among authors: llaneza p. Maturitas. 2022 Dec;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. Epub 2022 Aug 30. Maturitas. 2022. PMID: 36081216
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial.
Mendoza N, Diaz-Ropero MP, Aragon M, Maldonado V, Llaneza P, Lorente J, Mendoza-Tesarik R, Maldonado-Lobon J, Olivares M, Fonolla J. Mendoza N, et al. Among authors: llaneza p. Gynecol Endocrinol. 2019 Aug;35(8):695-700. doi: 10.1080/09513590.2019.1576620. Epub 2019 Mar 16. Gynecol Endocrinol. 2019. PMID: 30880505 Free article. Clinical Trial.
Esophageal-atrial fistula.
Lambert DR, Llaneza PP, Gaglani RD, Lach RD, Beaver WL. Lambert DR, et al. Among authors: llaneza pp. J Clin Gastroenterol. 1987 Jun;9(3):345-9. doi: 10.1097/00004836-198706000-00021. J Clin Gastroenterol. 1987. PMID: 3611691
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review.
Fiol G, Lete I, Nieto L, Santaballa A, Pla MJ, Baquedano L, Calaf J, Coronado P, de la Viuda E, Llaneza P, Otero B, Sánchez-Méndez S, Ramírez I, Mendoza N; “HMT Elegibility Criteria Group”. Fiol G, et al. Among authors: llaneza p. J Clin Med. 2023 Aug 12;12(16):5263. doi: 10.3390/jcm12165263. J Clin Med. 2023. PMID: 37629305 Free PMC article. Review.
Spanish consensus on premature menopause.
Mendoza N, Juliá MD, Galliano D, Coronado P, Díaz B, Fontes J, Gallo JL, García A, Guinot M, Munnamy M, Roca B, Sosa M, Tomás J, Llaneza P, Sánchez-Borrego R. Mendoza N, et al. Among authors: llaneza p. Maturitas. 2015 Feb;80(2):220-5. doi: 10.1016/j.maturitas.2014.11.007. Epub 2014 Dec 27. Maturitas. 2015. PMID: 25578643
Benefits of physical exercise in postmenopausal women.
Mendoza N, De Teresa C, Cano A, Godoy D, Hita-Contreras F, Lapotka M, Llaneza P, Manonelles P, Martínez-Amat A, Ocón O, Rodríguez-Alcalá L, Vélez M, Sánchez-Borrego R. Mendoza N, et al. Among authors: llaneza p. Maturitas. 2016 Nov;93:83-88. doi: 10.1016/j.maturitas.2016.04.017. Epub 2016 Apr 26. Maturitas. 2016. PMID: 27137981 Review.
Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis.
Coronado PJ, Gómez A, Iglesias E, Fasero M, Baquedano L, Sánchez S, Ramírez-Polo I, de la Viuda E, Otero B, Llaneza P, Mendoza N, Lubián DM; HMT Eligibility Criteria Group. Coronado PJ, et al. Among authors: llaneza p. Menopause. 2024 Mar 1;31(3):234-242. doi: 10.1097/GME.0000000000002317. Menopause. 2024. PMID: 38385734
What do TSECs provide in the menopausal hormone therapy?
Llaneza P, Calaf J, Jurado AR, Mendoza N, Otero B, Quereda F, Sánchez-Borrego R, Lubian D. Llaneza P, et al. Gynecol Endocrinol. 2018 Oct;34(10):826-832. doi: 10.1080/09513590.2018.1474869. Epub 2018 May 23. Gynecol Endocrinol. 2018. PMID: 29790381 Free article. Review.
Depressive disorders and the menopause transition.
Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR. Llaneza P, et al. Maturitas. 2012 Feb;71(2):120-30. doi: 10.1016/j.maturitas.2011.11.017. Epub 2011 Dec 21. Maturitas. 2012. PMID: 22196311 Review.
63 results